Chief Commercial Officer
Marty Siwak spearheads the commercialization of TeraPore’s proprietary nanofiltration membrane technology. He brings nearly four decades of experience developing and commercializing numerous separations and protein purification technologies to his role as Chief Commercial Officer. Prior to joining TeraPore, he served as Chief Technology Officer of JSR Life Sciences, where he was responsible for new technology development and integration of the company’s bioprocess product and services portfolio. Earlier in his tenure at JSR, he was Director of the Separations Sciences Group, where he was in charge of commercialization strategies and application development for the JSR Life Science Bioprocess Division. He began his distinguished life sciences career at Millipore holding a variety of engineering and R&D leadership positions during nearly 30 years at the company. Notably, as Director of the Worldwide Biomanufacturing Science Network at Millipore, he managed a global team of 90 engineers and scientists supporting process development and implementation of purification technologies for pharmaceutical and biopharmaceutical clients.
Mr. Siwak holds multiple patents and has published numerous articles related to biopharmaceutical processing. He received a dual B.S. degree in Chemical Engineering and Biochemistry from the University of Connecticut.